Humana (HUM) Scheduled to Post Earnings on Wednesday
Humana (NYSE:HUM) is scheduled to be releasing its Q313 earnings data on Wednesday, November 6th. Analysts expect Humana to post earnings of $2.14 per share and revenue of $10.27 billion for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
Humana (NYSE:HUM) opened at 94.13 on Tuesday. Humana has a one year low of $63.93 and a one year high of $99.85. The stock has a 50-day moving average of $94.2 and a 200-day moving average of $87.62. The company has a market cap of $14.728 billion and a P/E ratio of 9.90.
The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend is Friday, December 27th.
Several analysts have recently commented on the stock. Analysts at Deutsche Bank raised their price target on shares of Humana from $86.00 to $91.00 in a research note to investors on Tuesday, October 8th. They now have a “hold” rating on the stock. On a related note, analysts at JPMorgan Chase & Co. raised their price target on shares of Humana from $100.00 to $110.00 in a research note to investors on Thursday, September 5th. They now have an “overweight” rating on the stock. Finally, analysts at Zacks downgraded shares of Humana from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, September 4th. They now have a $99.00 price target on the stock. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $97.21.
Humana Inc (NYSE:HUM) is a health care company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.